Styliani Sympardi
Elefsina, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Pancreatic Stone Protein as an Early Prognostic Biomarker of Outcome in Clostridioides Difficile Infection.
Journal: Shock (Augusta, Ga.)
Published: December 22, 2025
Long-term immune and epigenetic dysregulation following COVID-19.
Journal: Clinical immunology (Orlando, Fla.)
Published: October 07, 2025
An NGS-assisted diagnostic workflow for culture-independent detection of bloodstream pathogens and prediction of antimicrobial resistances in sepsis.
Journal: Frontiers in cellular and infection microbiology
Published: June 29, 2025
Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial.
Journal: The Lancet regional health. Europe
Published: May 03, 2025
Clinical Phenotyping for Prognosis and Immunotherapy Guidance in Bacterial Sepsis and COVID-19.
Journal: Critical care explorations
Published: September 12, 2024
Assessment of De-Escalation of Empirical Antimicrobial Therapy in Medical Wards with Recognized Prevalence of Multi-Drug-Resistant Pathogens: A Multicenter Prospective Cohort Study in Non-ICU Patients with Microbiologically Documented Infection.
Journal: Antibiotics (Basel, Switzerland)
Published: July 22, 2024
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host.
Journal: International journal of antimicrobial agents
Published: April 10, 2024
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Respiratory medicine
Published: July 28, 2023
Epidemiology of Mucormycosis in Greece; Results from a Nationwide Prospective Survey and Published Case Reports.
Journal: Journal of fungi (Basel, Switzerland)
Published: February 05, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.
Journal: EClinicalMedicine
Published: October 10, 2022
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.
Journal: Cytokine
Published: October 09, 2022
Last Updated: 09/26/2026